Home > About Us > CNIO News, Year 2014

CNIO News, Year 2014

Logo CNIO

Spain to become a full member of Elixir, the European infrastructure for bioinformatics

Madrid, 17 December, 2014

Spain will become a full member of ELIXIR, the European bioinformatics infrastructure created to optimise biological data obtained from life sciences research. Spain participates in ELIXIR through the National Bioinformatics Institute (INB), a platform of the National Institute of Health Carlos III (ISCIII), whose central node is hosted at the Spanish National Cancer Research Centre (CNIO). Six INB institutions are participating in ELIXIR: the Spanish National Cancer Research Centre (CNIO), the...

Read more...
Logo CNIO

'CNIO Friends' invites society to join forces against cancer

Madrid, 9 December, 2014

Public perception reports for science show a growing interest in society towards patronage and new forms of citizen participation in research and science, particularly in the areas of medicine and health. Specifically, in the field of oncology, dedication and hard work in research and development is what allows us to say that, nowadays, nearly half of all cancers are curable. But there is still a long way to go: cancer is still the second most frequent cause of death in Spain, approximately...

Read more...
Logo CNIO

Obra Social 'la Caixa' remains strongly committed to research

Madrid, 9 December, 2014

The 18 research centres distinguished as Severo Ochoa Centres of Excellence are announcing the third edition of the “la Caixa”-Severo Ochoa International PhD Programme. This initiative, financed by Obra Social “la Caixa”, will provide support for hiring 46 students to carry out their doctoral thesis projects over the next four years. After an international selection process, scholarships will be awarded to students with the greatest talent and the best academic track record. Unanimously...

Read more...

"Lab Day 2014: A day of celebration by and for the CNIO"

Madrid, 4 December, 2014

Next Tuesday, December 9th, the Spanish National Cancer Research Centre (CNIO) celebrates its fourth Lab Day. The event, organised by the Office of Academic Affairs (Dean's Office) with CNIO pre-doctoral (CNIOSA) and postdoctoral (CNIO‐PDA) researchers, is designed to promote interactions between different research groups and to give visibility to their work.In the words of the Dean, Maria S. Soengas, this is “a day of celebration by and for CNIO” that always receives a great public response....

Read more...

A CNIO research, first successful case of the crowdfunding platform 'Precipita'

Madrid, 24 November, 2014

A research project from the Spanish National Cancer Research Centre (CNIO), focused on the detection of the most aggressive brain tumour—glioblastoma multiforme (GBM)—has reached its initial funding target of €25,000 in just over a month on the crowdfunding platform Precipita. The project represents the first successful case for the platform, which belongs to the Spanish Foundation for Science & Technology (FECYT), launched in October.Thanks to the show of citizen solidarity, the research...

Read more...
Logo CNIO

CNIO opens its doors for European Researchers’ Night 2014

Madrid, 23 September, 2014

Once again, the Spanish National Cancer Research Centre (CNIO) will join one of the most anticipated events to popularise science in Europe, to be held on Friday, September 26: European Researchers' Night. With the slogan Meet the researchers, be a researcher, CNIO scientists will put their experiments on hold for a few hours to attract interest in science among the young –and not so young– and to show them the value of their work in everyday life.After the activity´s success in 2013, this year...

Read more...
Logo CNIO

María Blasco receives an honorary degree from Carlos III University of Madrid

Madrid, 10 September, 2014

The Director of the Spanish National Cancer Research Centre (CNIO), Maria Blasco, will be awarded an honorary degree from the Carlos III University of Madrid (UC3M) on Friday, September 12, alongside the winner of the Nobel Prize for Literature, Mario Vargas Llosa.The ceremony will take place in the Great Hall (Aula Magna) of UC3M’s Getafe campus and will be held during the year’s special opening ceremony, as the main event to celebrate the 25th anniversary of the university.Maria Blasco...

Read more...

Eva Nogales explains the new revolution in structural biology at CNIO

Madrid, 12 August, 2014

The Spanish biophysicist Eva Nogales, a professor at the University of California, Berkeley (US) and the Lawrence Berkeley National Laboratory, is a global leader in researching the structure of large biological molecules. Her research on the tubulin protein, for example, has recently revealed how the Taxol anti-cancer drug works. Nogales has spent a month at CNIO thanks to the Jesús Serra Foundation’s Visiting Researchers Programme, sharing her experience with the centre’s structural biology...

Read more...
Logo CNIO

CNIO researcher Elena Castro receives the Juan Letona Award in Translational Medicine

Madrid, 4 July, 2014

Elena Castro, a clinical researcher in the Prostate Cancer and Genitourinary Tumours Clinical Research Unit at the Spanish National Cancer Research Centre (CNIO), has been honoured with the Juan Letona Award in Traslational Medicine, organised by the Hospital de Madrid Foundation. The award, now in its Xth edition, recognises the research published last year by Castro in the Journal of Clinical Oncology. In collaboration with researchers from the Institute of Cancer Research and the Royal...

Read more...

University students from several countries spend the summer at CNIO

Madrid, 30 June, 2014

From June 23 to August 14, many of the staff at the Spanish National Cancer Research Centre (CNIO) will most likely bump into younger students than normal in the corridors, cell culture labs or the cafeteria. Everything is under control: it’s the university students who have chosen a BIO destination at CNIO for the summer; eight university students—from Argentina, Bangladesh, the US, India, Italy and Spain— in their last two course years of a biomedical sciences degree or related.They have been...

Read more...

CNIO and the Jesús Serra Foundation welcome the ‘Visiting Researchers’ for 2014

Madrid, 4 June, 2014

Yesterday, the Spanish National Cancer Research Centre (CNIO) and the Jesús Serra Foundation officially welcomed the beneficiaries of the Jesús Serra Foundation’s Visiting Researchers Programme for 2014. During the event, which took place at the CNIO, Peter Petzelbauer -from the Medical University of Vienna‐ and André Nussenzweig -from the US National Cancer Institute- outlined the main objectives of their collaborative research projects that will be carried out during their stay at the...

Read more...
Logo CNIO

Two CNIO researchers have participated in a review chosen among the best ‘Cell’ studies of 2013

Madrid, 20 May, 2014

Ageing is a primary risk factor for major human pathologies; it is a process intimately related to the life span whose delay could help us to understand and combat diseases such as cancer, diabetes or Alzheimer’s. This is one of the conclusions of the study The Hallmarks of Aging -a review that describes for the first time all the molecular indicators of ageing in mammals- which has just been recognised as one of the best and more relevant scientific articles of 2013, according to the journal...

Read more...

CNIO scientist among the 40 most important global researchers

Madrid, 7 May, 2014

Science, Nature and Cell are without doubt three aces in the pack of global scientific publications. The last of these is celebrating its 40th Anniversary in 2014, so its editors have decided to draw up a list of the 40 most relevant researchers in the world that have not yet reached the age of 40 (http://www.cell.com/40/under40).Getting on the list of an elite new generation of international researchers is no easy task as Cell is constantly reviewing the very best scientific results so,...

Read more...
Logo CNIO

Diálogo Awards Prize to CNIO and Institut Curie

Madrid, 5 May, 2014

The Spanish National Cancer Research Centre (CNIO) and the Institut Curie have been awarded the 11th Diálogo Prize for Franco‐Hispanic Friendship in recognition for their world-leading contributions to the prevention, diagnosis and treatment of cancer. Maria Blasco, Director of the CNIO, and Thierry Philip, President of the Institut Curie will receive the award at the ceremony that will take place on June 10 in Madrid.The jury of the 11th Diálogo Prize, presided by Rafael Arias‐Salgado, has...

Read more...
Logo CNIO

CNIO and the Roche Institute will bring advances in hereditary cancer closer to different professional groups

Madrid, 30 April, 2014

With the aim of improving knowledge and care of hereditary cancer in primary health care system, the Spanish National Cancer Research Centre (CNIO) and the Roche Institute have reached a specific collaboration agreement that will serve to implement an ambitious training programme. The agreement, which is included within a broad, well-established framework of understanding between both institutions, will be directed mainly towards familial physicians and primary health care professionals.As the...

Read more...
Logo CNIO

CNIO researcher Manuel Hidalgo awarded the ‘El Talento’ Prize

Madrid, 20 March, 2014

The Director of the Spanish National Cancer Research Centre’s (CNIO) Clinical Research Programme, Manuel Hidalgo, has been awarded the El Talento 2013 Prize by the newspaper Cinco Días. The CNIO researcher is proud to receive the award in the AcademicTalent category, which recognises people who prioritise research and learning as forms of development, bringing them to the worlds of education and science.Manuel Hidalgo was educated at Spanish universities and specialised in Medical Oncology at...

Read more...
Logo CNIO

CNIO-Merck alliance receives prize from 'Correo Farmacéutico'

Madrid, 18 March, 2014

Once more, Correo Farmacéutico, one of the most prestigious Spanish journals in the health field, has selected the winners for the Best Initiatives in Pharmacy of 2013. In this year’s awards, the alliance between CNIO and the pharmaceutical company Merck has received an award as one of the best initiatives in the Pharmacological Research and Products category.The prizes -which recognise the day-to-day efforts of those people, institutions and companies which have contributed to pharmacology,...

Read more...

CNIO researcher becomes first Spanish scientist awarded by the ‘Prostate Cancer Foundation’

Madrid, 12 March, 2014

David Olmos, the Spanish National Cancer Research Centre's (CNIO) Head of the Prostate Cancer and Genitourinary Tumours Clinical Research Unit, has won the 2014 Stewart Rahr‐PCF Young Investigator Award, endowed by the Prostate Cancer Foundation (PCF) — the leading philanthropic organisation for cutting- edge research into prostate cancer. Olmos is the first Spanish scientist and one of a select number of European researchers to receive this prestigious award, which is normally awarded to...

Read more...

CNIO scientist wins one of the most prestigious research grants in the world for the second time

Madrid, 14 January, 2014

Óscar Fernández-Capetillo’s research group has developed compounds that only a few weeks ago were licensed by the Spanish National Cancer Research Centre (CNIO) to a pharmaceutical company for the creation of new anti-tumour drugs. This is one of the least frequent but most desired project outcomes for cancer researchers. Fernández-Capetillo can now celebrate a new achievement: the awarding by the European Research Council (ERC) of a €2 million Consolidator Grant, one of the most prestigious...

Read more...